DCF — INTEGRIS BAPTIST MEDICAL CENTER
Enterprise Value: $-1.4B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.4B
Enterprise Value
$-456.2M
PV of Cash Flows
$-968.7M
PV of Terminal Value
$-1.6B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.1B | $-85.8M | -8.0% | $-130.4M | $-118.5M |
| Year 2 | $1.1B | $-77.6M | -7.0% | $-123.4M | $-102.0M |
| Year 3 | $1.1B | $-68.7M | -6.0% | $-116.0M | $-87.1M |
| Year 4 | $1.1B | $-65.0M | -6.0% | $-113.7M | $-77.7M |
| Year 5 | $1.2B | $-64.0M | -5.0% | $-114.2M | $-70.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.4B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.0B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.08657267975641819
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5